Endogenous Secretory Receptor for Advanced Glycation Endproducts Levels Are Correlated With Serum Pentosidine and CML in Patients With Type 1 Diabetes
Authors:
- Junnosuke MiuraJMJunnosuke Miura
- Takuo WatanabeTWTakuo Watanabe
- Yasuko UchigataYUYasuko Uchigata
- Yamagishi SYSYamagishi S
- Imaizumi TITImaizumi T
- Miura JMJMiura J
- Sakurai SSSSakurai S
- 1 January 2007
- journal article
- letter
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 27 (1) , 253-254
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patientsDiabetes Research and Clinical Practice, 2006
- Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- AGE down-regulation of monocyte RAGE expression and its association with diabetic complications in type 1 diabetesJournal of Diabetes and its Complications, 2004
- Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injuryBiochemical Journal, 2003
- Lymphocytes are important in early atherosclerosisJournal of Clinical Investigation, 2001
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999